Schedule 13D ownership disclosure

Phathom Pharmaceuticals Inc

Common Stock, $0.0001 par value per share · CUSIP: 71722W107

Event date: 2025-05-09

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Frazier Life Sciences Public Fund, L.P.Reported CIK 0001863769

    Shares: 5,738,457.00 · Class: 8.0%

  • FHMLSP, L.P.Reported CIK 0001879466

    Shares: 5,738,457.00 · Class: 8.0%

  • FHMLSP, L.L.C.Reported CIK 0001879465

    Shares: 5,738,457.00 · Class: 8.0%

  • Frazier Life Sciences Public Overage Fund, L.P.Reported CIK 0001913804

    Shares: 1,531,870.00 · Class: 2.2%

  • FHMLSP Overage, L.P.Reported CIK 0001963247

    Shares: 1,531,870.00 · Class: 2.2%

  • FHMLSP Overage, L.L.C.Reported CIK 0001963248

    Shares: 1,531,870.00 · Class: 2.2%

  • Frazier Life Sciences X, L.P.Reported CIK 0001790879

    Shares: 48,203.00 · Class: 0.1%

  • FHMLS X, L.P.Reported CIK 0001790880

    Shares: 48,203.00 · Class: 0.1%

  • FHMLS X, L.L.C.Reported CIK 0001790811

    Shares: 48,203.00 · Class: 0.1%

  • Frazier Life Sciences XI, L.P.Reported CIK 0001911592

    Shares: 961,550.00 · Class: 1.4%

  • FHMLS XI, L.P.Reported CIK 0001911580

    Shares: 961,550.00 · Class: 1.4%

  • FHMLS XI, L.L.C.Reported CIK 0001911623

    Shares: 961,550.00 · Class: 1.4%

  • Frazier Life Sciences IX, L.P.Reported CIK 0001720320

    Shares: 5,827,415.00 · Class: 8.3%

  • FHMLS IX, L.P.Reported CIK 0001782789

    Shares: 5,827,415.00 · Class: 8.3%

  • FHMLS IX, L.L.C.Reported CIK 0001782791

    Shares: 5,827,416.00 · Class: 8.3%

  • Frazier Life Sciences XII, L.P.Reported CIK 0002052255

    Shares: 223,986.00 · Class: 0.3%

  • FHMLS XII, L.P.Reported CIK 0002052246

    Shares: 223,986.00 · Class: 0.3%

  • FHMLS XII, L.L.C.Reported CIK 0002052177

    Shares: 223,986.00 · Class: 0.3%

  • James N. TopperReported CIK 0001341382

    Shares: 14,429,990.00 · Class: 19.9%

  • Patrick J. HeronReported CIK 0001365617

    Shares: 14,346,419.00 · Class: 19.9%

  • Albert ChaReported CIK 0001397906

    Shares: 7,270,327.00 · Class: 10.1%

  • James BrushReported CIK 0001865123

    Shares: 7,270,327.00 · Class: 10.1%

  • Daniel EstesReported CIK 0001702527

    Shares: 1,185,536.00 · Class: 1.7%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001415889-25-012779
Form type
SCHEDULE 13D/A
Filer
Frazier Life Sciences Public Fund, L.P.
CIK
CIK 1863769
Filed
May 13, 2025
Reporting period
May 09, 2025
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub